Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514918 | SCV000609951 | likely benign | not provided | 2017-05-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514918 | SCV001816470 | likely benign | not provided | 2019-03-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002524979 | SCV003698951 | uncertain significance | Inborn genetic diseases | 2021-07-27 | criteria provided, single submitter | clinical testing | The c.152C>A (p.P51Q) alteration is located in exon 1 (coding exon 1) of the NDUFB11 gene. This alteration results from a C to A substitution at nucleotide position 152, causing the proline (P) at amino acid position 51 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV000514918 | SCV001797585 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000514918 | SCV001963659 | likely benign | not provided | no assertion criteria provided | clinical testing |